Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

INFED 100 MG/2 ML VIAL

Iron Dextran
$18.9002per ML

Strength

50 mg/mL

Manufacturer

Allergan, Inc.

NDC

00023608210

Classification

Brand

Dosage Form

INJECTION

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

1/2/2026

Active Ingredients

IRON DEXTRAN

Approval Type

New Drug (NDA)

FDA Application

NDA017441

On Market Since

4/29/1974

Pharmacological Classes

Iron
Parenteral Iron Replacement
Phosphate Binder
Phosphate Chelating Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.9%

1Y

+4.6%

3Y

N/A

5Y

N/A

All

+9.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TUMS TABLET CHEWABLE
Brand
00135007003•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007027•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007048•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007127•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007148•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135061101•Haleon US Holdings LLC
$0.0274
per EA
TUMS ULTRA TABLET CHEWABLE
Brand
00135018301•Haleon US Holdings LLC
$0.0525
per EA
TUMS E-X TABLET CHEWABLE
Brand
00135015405•Haleon US Holdings LLC
$0.0602
per EA
TUMS SMOOTHIES CHEW TABLET
Brand
00135024502•Haleon US Holdings LLC
$0.0602
per EA
TUMS E-X TABLET CHEWABLE
Brand
00135007625•Haleon US Holdings LLC
$0.0631
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy